{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:36:36Z","timestamp":1757619396858,"version":"3.44.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01GM136804","5U01AI138318","5U01AI138318","5R01GM136804","5R01GM136804"],"award-info":[{"award-number":["5R01GM136804","5U01AI138318","5U01AI138318","5R01GM136804","5R01GM136804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sepsis is a complex and life-threatening disease process related to a systemic response to severe infection. Due to the challenges of treating patients with sepsis, new therapies are being investigated, including cell-based approaches. Trophoblast stem cells (TSCs) are immune privileged cells with immunomodulatory properties. Thus, we proposed that TSCs may be beneficial in experimental models of sepsis to regulate the immune response and curtail organ injury.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Sepsis was induced by experimental models in mice; cecal ligation and puncture (CLP) and lung infection with <jats:italic>Streptococcus (S.) pneumoniae.<\/jats:italic> TSCs were isolated from the chorionic villi of human (h) term placentas, and from mouse (m) placentas using anti-CD117 MicroBeads, and were administered intravenously 6\u00a0h after CLP or <jats:italic>S. pneumoniae<\/jats:italic> infection. We assessed mortality, bacterial clearance, organ injury, inflammatory response, and production of cytokines and chemokines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CD117<jats:sup>+<\/jats:sup> hTSCs did not express human leukocyte antigen (HLA) I or II, and were clonogenic and self-renewing. CLP led to severe mortality by 7 days, and administration of either hTSCs or mTSCs resulted in markedly improved survival compared with control cells or vehicle. hTSCs promoted bacterial clearance and decreased organ injury in the liver, kidney, spleen, and bowel. The elevated innate immune response in the peritoneum, predominantly neutrophils, was attenuated by hTSCs. In addition, neutrophil infiltration into the spleen was less in mice receiving hTSCs, which corresponded with reduced plasma pro-inflammatory cytokines and chemokines. When assessing the lung response to <jats:italic>S. pneumoniae<\/jats:italic> infection, administration of hTSCs resulted in fewer bacteria in bronchoalveolar lavage fluid (BALF) and lung tissue, and less lung edema and injury. Neutrophils, which were markedly increased in BALF, were diminished and infiltration of neutrophils and macrophages into the lungs was decreased by hTSCs. BALF pro-inflammatory cytokines and chemokines were mitigated by hTSCs to levels of Sham mice, and systemic injury to the liver and spleen was attenuated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CD117<jats:sup>+<\/jats:sup> hTSCs are immune privileged cells that when given after the onset of experimental models of infection\/sepsis resulted in improved outcomes due to enhanced bacterial clearance, resolving inflammation, and less organ injury. These data support hTSCs as a potential cell-based therapy for sepsis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13287-025-04479-z","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T20:26:43Z","timestamp":1753129603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic impact of human trophoblast stem cells in peritoneal and pneumonia-induced sepsis in mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Narae","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Murzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassidy J.","family":"Mays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Perrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"4479_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303\u201310.","journal-title":"Crit Care Med"},{"key":"4479_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138\u201350.","journal-title":"N Engl J Med"},{"issue":"9","key":"4479_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"4479_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of Hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4479_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","volume":"40","author":"T Lagu","year":"2012","unstructured":"Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the united States 2003 to 2007. Crit Care Med. 2012;40(3):754\u201361.","journal-title":"Crit Care Med"},{"issue":"6","key":"4479_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/ALN.0000000000001882","volume":"127","author":"C Keane","year":"2017","unstructured":"Keane C, Jerkic M, Laffey JG. Stem Cell-based therapies for Sepsis. Anesthesiology. 2017;127(6):1017\u201334.","journal-title":"Anesthesiology"},{"issue":"1","key":"4479_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25(1):19\u201328.","journal-title":"Nat Immunol"},{"key":"4479_CR8","doi-asserted-by":"publisher","first-page":"103832","DOI":"10.1016\/j.ebiom.2022.103832","volume":"76","author":"J Varon","year":"2022","unstructured":"Varon J, Baron RM. Sepsis endotypes: the early bird still gets the worm. EBioMedicine. 2022;76:103832.","journal-title":"EBioMedicine"},{"key":"4479_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2018.04.006","volume":"199","author":"X He","year":"2018","unstructured":"He X, Ai S, Guo W, Yang Y, Wang Z, Jiang D, et al. Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: A phase 1 clinical trial. Transl Res. 2018;199:52\u201361.","journal-title":"Transl Res"},{"key":"4479_CR10","doi-asserted-by":"publisher","first-page":"9222379","DOI":"10.1155\/2022\/9222379","volume":"2022","author":"E Alp","year":"2022","unstructured":"Alp E, Gonen ZB, Gundogan K, Esmaoglu A, Kaynar L, Cetin A, et al. The effect of mesenchymal stromal cells on the mortality of patients with Sepsis and septic shock: A promising therapy. Emerg Med Int. 2022;2022:9222379.","journal-title":"Emerg Med Int"},{"issue":"1","key":"4479_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","volume":"27","author":"F Wang","year":"2023","unstructured":"Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):31.","journal-title":"Crit Care"},{"issue":"7","key":"4479_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58(7):929\u201339.","journal-title":"Gut"},{"issue":"1","key":"4479_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42\u20139.","journal-title":"Nat Med"},{"issue":"8","key":"4479_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","volume":"182","author":"SH Mei","year":"2010","unstructured":"Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in Sepsis. Am J Respir Crit Care Med. 2010;182(8):1047\u201357.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"4479_CR15","doi-asserted-by":"publisher","first-page":"L1003","DOI":"10.1152\/ajplung.00180.2011","volume":"302","author":"A Krasnodembskaya","year":"2012","unstructured":"Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol. 2012;302(10):L1003\u201313.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"4479_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/stem.1270","volume":"31","author":"SR Hall","year":"2013","unstructured":"Hall SR, Tsoyi K, Ith B, Padera RF Jr., Lederer JA, Wang Z, et al. Mesenchymal stromal cells improve survival during Sepsis in the absence of Heme Oxygenase-1: the importance of neutrophils. Stem Cells. 2013;31(2):397\u2013407.","journal-title":"Stem Cells"},{"issue":"12","key":"4479_CR17","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1097\/CCM.0000000000001999","volume":"44","author":"K Tsoyi","year":"2016","unstructured":"Tsoyi K, Hall SR, Dalli J, Colas RA, Ghanta S, Ith B, et al. Carbon monoxide improves efficacy of mesenchymal stromal cells during Sepsis by production of specialized proresolving lipid mediators. Crit Care Med. 2016;44(12):e1236\u201345.","journal-title":"Crit Care Med"},{"issue":"5","key":"4479_CR18","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1097\/CCM.0000000000004244","volume":"48","author":"MY Kwon","year":"2020","unstructured":"Kwon MY, Ghanta S, Ng J, Tsoyi K, Lederer JA, Bronson RT, et al. Expression of stromal Cell-Derived Factor-1 by mesenchymal stromal cells impacts neutrophil function during Sepsis. Crit Care Med. 2020;48(5):e409\u201317.","journal-title":"Crit Care Med"},{"issue":"2","key":"4479_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/febs.16154","volume":"289","author":"J Han","year":"2021","unstructured":"Han J, Shi Y, Willis G, Imani J, Kwon MY, Li G, et al. Mesenchymal stromal Cell-Derived Syndecan-2 regulates the immune response during Sepsis to foster bacterial clearance and resolution of inflammation. FEBS J. 2021;289(2):417\u201335.","journal-title":"FEBS J"},{"issue":"7","key":"4479_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.ymthe.2024.05.018","volume":"32","author":"N Hwang","year":"2024","unstructured":"Hwang N, Ghanta S, Li Q, Lamattina AM, Murzin E, Lederer JA, et al. Carbon monoxide-induced autophagy enhances human mesenchymal stromal cell function via paracrine actions in murine polymicrobial sepsis. Mol Ther. 2024;32(7):2232\u201347.","journal-title":"Mol Ther"},{"issue":"1","key":"4479_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-020-1567-4","volume":"11","author":"M Hou","year":"2020","unstructured":"Hou M, Han J, Li G, Kwon MY, Jiang J, Emani S, et al. Multipotency of mouse trophoblast stem cells. Stem Cell Res Ther. 2020;11(1):55.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4479_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s13287-021-02550-z","volume":"12","author":"J Han","year":"2021","unstructured":"Han J, Li G, Hou M, Ng J, Kwon MY, Xiong K, et al. Intratracheal transplantation of trophoblast stem cells attenuates acute lung injury in mice. Stem Cell Res Ther. 2021;12(1):487.","journal-title":"Stem Cell Res Ther"},{"issue":"Suppl 1","key":"4479_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.shk.0000191414.94461.7e","volume":"24","author":"WJ Hubbard","year":"2005","unstructured":"Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, et al. Cecal ligation and puncture. Shock. 2005;24(Suppl 1):52\u20137.","journal-title":"Shock"},{"issue":"4","key":"4479_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/CMR.00012-08","volume":"21","author":"D Chiavolini","year":"2008","unstructured":"Chiavolini D, Pozzi G, Ricci S. Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev. 2008;21(4):666\u201385.","journal-title":"Clin Microbiol Rev"},{"key":"4479_CR25","first-page":"203","volume":"121","author":"MG Petroff","year":"2006","unstructured":"Petroff MG, Phillips TA, Ka H, Pace JL, Hunt JS. Isolation and culture of term human trophoblast cells. Methods Mol Med. 2006;121:203\u201317.","journal-title":"Methods Mol Med"},{"key":"4479_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1172\/JCI32730","volume":"118","author":"SW Chung","year":"2008","unstructured":"Chung SW, Liu X, Macias AA, Baron RM, Perrella MA. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest. 2008;118:239\u201347.","journal-title":"J Clin Invest"},{"issue":"1","key":"4479_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/CCM.0b013e3181b4a76b","volume":"38","author":"KW McConnell","year":"2010","unstructured":"McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, Turnbull IR, et al. Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med. 2010;38(1):223\u201341.","journal-title":"Crit Care Med"},{"issue":"19","key":"4479_CR28","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1182\/bloodadvances.2020002556","volume":"4","author":"J Ng","year":"2020","unstructured":"Ng J, Guo F, Marneth AE, Ghanta S, Kwon MY, Keegan J, et al. Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis. Blood Adv. 2020;4(19):4965\u201379.","journal-title":"Blood Adv"},{"issue":"4","key":"4479_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/JLB.4HI0817-333RR","volume":"104","author":"RM Baron","year":"2018","unstructured":"Baron RM, Kwon MY, Castano AP, Ghanta S, Riascos-Bernal DF, Lopez-Guzman S, et al. Frontline science: targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis. J Leukoc Biol. 2018;104(4):677\u201389.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"4479_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4049\/jimmunol.1500597","volume":"196","author":"L Wanke-Jellinek","year":"2016","unstructured":"Wanke-Jellinek L, Keegan JW, Dolan JW, Guo F, Chen J, Lederer JA. Beneficial effects of CpG-Oligodeoxynucleotide treatment on trauma and secondary lung infection. J Immunol. 2016;196(2):767\u201377.","journal-title":"J Immunol"},{"issue":"24","key":"4479_CR31","doi-asserted-by":"publisher","first-page":"11786","DOI":"10.1073\/pnas.1811827116","volume":"116","author":"S Vadakke-Madathil","year":"2019","unstructured":"Vadakke-Madathil S, LaRocca G, Raedschelders K, Yoon J, Parker SJ, Tripodi J, et al. Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart. Proc Natl Acad Sci U S A. 2019;116(24):11786\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4479_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1189\/jlb.0912437","volume":"93","author":"M Aziz","year":"2013","unstructured":"Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and Immunomodulatory mediators in sepsis. J Leukoc Biol. 2013;93(3):329\u201342.","journal-title":"J Leukoc Biol"},{"key":"4479_CR33","doi-asserted-by":"publisher","first-page":"960327122107887","DOI":"10.1177\/09603271221078871","volume":"41","author":"Z Doganyigit","year":"2022","unstructured":"Doganyigit Z, Eroglu E, Akyuz E. Inflammatory mediators of cytokines and chemokines in sepsis: from bench to bedside. Hum Exp Toxicol. 2022;41:9603271221078871.","journal-title":"Hum Exp Toxicol"},{"issue":"9","key":"4479_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00134-002-1416-1","volume":"28","author":"V Pettila","year":"2002","unstructured":"Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and Interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002;28(9):1220\u20135.","journal-title":"Intensive Care Med"},{"issue":"7","key":"4479_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00011-009-0003-0","volume":"58","author":"HP Wu","year":"2009","unstructured":"Wu HP, Chen CK, Chung K, Tseng JC, Hua CC, Liu YC, et al. Serial cytokine levels in patients with severe sepsis. Inflamm Res. 2009;58(7):385\u201393.","journal-title":"Inflamm Res"},{"issue":"6","key":"4479_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","volume":"9","author":"OJ McElvaney","year":"2021","unstructured":"McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: Obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021;9(6):643\u201354.","journal-title":"Lancet Respir Med"},{"key":"4479_CR37","doi-asserted-by":"publisher","first-page":"107783","DOI":"10.1016\/j.intimp.2021.107783","volume":"96","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang H, Guo R, Li X, Liu H, Wang Z, et al. MicroRNA-223 modulates the IL-4-medicated macrophage M2-type polarization to control the progress of sepsis. Int Immunopharmacol. 2021;96:107783.","journal-title":"Int Immunopharmacol"},{"key":"4479_CR38","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola A, Munari F, Sanchez-Rodriguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol. 2019;10:1462.","journal-title":"Front Immunol"},{"key":"4479_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.08.014","volume":"31","author":"E Antoniadou","year":"2016","unstructured":"Antoniadou E, David AL. Placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2016;31:13\u201329.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"4479_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.stemcr.2016.01.006","volume":"6","author":"CQ Lee","year":"2016","unstructured":"Lee CQ, Gardner L, Turco M, Zhao N, Murray MJ, Coleman N, et al. What is trophoblast?? A combination of criteria define human First-Trimester trophoblast?. Stem Cell Rep. 2016;6(2):257\u201372.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4479_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2017.11.004","volume":"22","author":"H Okae","year":"2018","unstructured":"Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K, et al. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22(1):50\u201363. e6.","journal-title":"Cell Stem Cell"},{"issue":"1Suppl 1","key":"4479_CR42","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.placenta.2017.01.003","volume":"60","author":"CW Chang","year":"2017","unstructured":"Chang CW, Parast MM. Human trophoblast stem cells: real or not real? Placenta. 2017;60(1Suppl 1):S57\u201360.","journal-title":"Placenta"},{"key":"4479_CR43","doi-asserted-by":"crossref","unstructured":"Vadakke-Madathil S, Bouhamida E, Wang B, Mathiyalagan P, Oniskey M, Santos-Gallego C et al. Discovery of a multipotent cell type from the term human placenta. BioRxiv. 2024.","DOI":"10.1101\/2023.08.02.551028"},{"key":"4479_CR44","doi-asserted-by":"publisher","first-page":"10054","DOI":"10.1038\/srep10054","volume":"5","author":"S Mathews","year":"2015","unstructured":"Mathews S, Lakshmi Rao K, Suma Prasad K, Kanakavalli MK, Govardhana Reddy A, Avinash Raj T, et al. Propagation of pure fetal and maternal mesenchymal stromal cells from terminal chorionic villi of human term placenta. Sci Rep. 2015;5:10054.","journal-title":"Sci Rep"},{"issue":"5","key":"4479_CR45","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.stem.2022.04.004","volume":"29","author":"RM Karvas","year":"2022","unstructured":"Karvas RM, Khan SA, Verma S, Yin Y, Kulkarni D, Dong C, et al. Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens. Cell Stem Cell. 2022;29(5):810\u201325. e8.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4479_CR46","doi-asserted-by":"publisher","first-page":"e0193523","DOI":"10.1128\/jvi.01935-23","volume":"98","author":"TB Rollman","year":"2024","unstructured":"Rollman TB, Berkebile ZW, Okae H, Bardwell VJ, Gearhart MD, Bierle CJ. Human trophoblast stem cells restrict human cytomegalovirus replication. J Virol. 2024;98(4):e0193523.","journal-title":"J Virol"},{"issue":"1","key":"4479_CR47","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/s41467-023-41158-0","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Huang XY, Sun MX, Wang Y, Zhou HY, Tian Y, et al. Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. Nat Commun. 2023;14(1):5541.","journal-title":"Nat Commun"},{"issue":"24","key":"4479_CR48","first-page":"2382","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Team CES. Community-Acquired pneumonia requiring hospitalization. N Engl J Med. 2015;373(24):2382.","journal-title":"N Engl J Med"},{"issue":"4","key":"4479_CR49","doi-asserted-by":"publisher","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","volume":"8","author":"MA Said","year":"2013","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O\u2019Brien KL, Team AAPBS, et al. Estimating the burden of Pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS ONE. 2013;8(4):e60273.","journal-title":"PLoS ONE"},{"issue":"8","key":"4479_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"1","key":"4479_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330\u201353.","journal-title":"Immunol Rev"},{"key":"4479_CR52","doi-asserted-by":"publisher","first-page":"615009","DOI":"10.3389\/fimmu.2020.615009","volume":"11","author":"A Fabri","year":"2020","unstructured":"Fabri A, Kandara K, Coudereau R, Gossez M, Abraham P, Monard C, et al. Characterization of Circulating IL-10-Producing cells in septic shock patients: A proof of concept study. Front Immunol. 2020;11:615009.","journal-title":"Front Immunol"},{"issue":"4","key":"4479_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0883-9441(97)90030-7","volume":"12","author":"G Friedman","year":"1997","unstructured":"Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. Blood Interleukin 10 levels parallel the severity of septic shock. J Crit Care. 1997;12(4):183\u20137.","journal-title":"J Crit Care"},{"issue":"9","key":"4479_CR54","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","volume":"7","author":"DP Schrijver","year":"2023","unstructured":"Schrijver DP, Roring RJ, Deckers J, de Dreu A, Toner YC, Prevot G, et al. Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells. Nat Biomed Eng. 2023;7(9):1097\u2013112.","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"4479_CR55","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.yexcr.2010.03.003","volume":"316","author":"B Henriques-Normark","year":"2010","unstructured":"Henriques-Normark B, Normark S. Commensal pathogens, with a focus on Streptococcus pneumoniae, and interactions with the human host. Exp Cell Res. 2010;316(8):1408\u201314.","journal-title":"Exp Cell Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04479-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:10:22Z","timestamp":1757272222000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04479-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04479-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human Cells: The trophoblast stem cells were harvested from human term placental tissue. All of the tissue was from discarded placental specimens, de-identified prior to collection by the research team. Thus, the study was considered to be Not Human Subjects Research by the Brigham and Women\u2019s Hospital Institutional Review Board (Record ID 1830).Animal Ethics declaration: Studies using mice were carried out in accordance with the Public Health Service policy on the humane care and use of laboratory animals, and approved by the Institutional Animal Care and Use Committee (IACUC) of Brigham and Women\u2019s Hospital (Protocol 2016N000308). As per our IACUC protocol, with major surgical procedures, analgesics were used. Moreover, the use of humane endpoints was applied during the survival experiments in the CLP model of sepsis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}